Stock Fundamentals

Company Information

Company Name
Inovio Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US45773H4092
CIK: 0001055726
CUSIP: 371916305
Currency: USD
Full Time Employees: 112
Phone: 267 440 4200
Fiscal Year End: December
IPO Date: Feb 12, 1998
Description:

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company's lead product candidate is INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade squamous intraepithelial lesions; INO-3112 for the treatment of HPV-related Oropharyngeal squamous cell carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 2/3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. The company's partners and collaborators ApolloBio Corporation, AstraZeneca, Coherus Biosciences, Defense Advanced Research Projects Agency, HIV Vaccines Trial Network, Kaneka Eurogentec, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the University of Pennsylvania, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

Address:

660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462

Directors & Officers

Name Title Year Born
Dr. Jacqueline E. Shea Ph.D. CEO, President & Director 1966
Mr. Peter D. Kies Chief Financial Officer 1963
Dr. Michael Sumner B.S., M.B.A., M.D. Chief Medical Officer & Head of Development 1965
Dr. Laurent M. Humeau Ph.D. Chief Scientific Officer & Chairman of the Scientific Advisory Board 1967
Mr. Robert L. Crotty J.D. General Counsel, Corporate Secretary & Chief Compliance Officer 1974
Ms. Jennie Willson Director of Communications NA
Mr. E. J. Brandreth MBA Senior Vice President of Quality Assurance NA
Dr. Jeffrey Skolnik M.D. Senior Vice President of Clinical Development NA
Mr. Robert J. Juba Jr. Senior Vice President of Biological Manufacturing & Clinical Supply Management NA
Mr. Shawn D. Bridy M.A., M.B.A. Senior Vice President of Business Development NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 13, 2023 David B Weiner N/A Sale 40.00 $165.60 $6.62K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
FMR Inc 9.34M Mar 31, 2026 11.35% $0.00 -5.15%
Vanguard Group Inc 3.32M Dec 31, 2025 4.03% $0.00 22.22%
HHG PLC 3.31M Mar 31, 2026 4.02% $0.00 0.00%
Vanguard Capital Management, LLC 2.90M Mar 31, 2026 3.53% $0.00 0.00%
Boxer Capital Management, LLC 2.37M Mar 31, 2026 2.88% $0.54 -2.07%
D. E. Shaw & Co LP 2.21M Mar 31, 2026 2.69% $0.00 -0.85%
ADAR1 Capital Management LLC 1.47M Mar 31, 2026 1.79% $0.15 -1.00%
Millennium Management LLC 1.41M Mar 31, 2026 1.71% $0.00 0.53%
Eversept Partners, LP 1.04M Mar 31, 2026 1.26% $0.10 0.00%
Adage Capital Partners Gp LLC 804.96K Mar 31, 2026 0.98% $0.00 -68.48%
Geode Capital Management, LLC 801.50K Mar 31, 2026 0.97% $0.00 4.18%
BlackRock Inc 662.18K Mar 31, 2026 0.80% $0.00 7.17%
Renaissance Technologies Corp 643.78K Mar 31, 2026 0.78% $0.00 16.38%
Diadema Partners LP 562.67K Mar 31, 2026 0.68% $0.17 5.43%
Vanguard Fiduciary Trust Co 392.07K Mar 31, 2026 0.48% $0.00 0.00%
Two Sigma Investments LLC 390.38K Mar 31, 2026 0.47% $0.00 20.96%
Northern Trust Corp 298.87K Mar 31, 2026 0.36% $0.00 -0.37%
State Street Corp 296.31K Mar 31, 2026 0.36% $0.00 19.76%
Citadel Advisors Llc 286.35K Mar 31, 2026 0.35% $0.00 0.00%
GSA Capital Partners LLP 265.08K Mar 31, 2026 0.32% $0.03 -42.35%

Shares Statistics

Shares Outstanding: 82.27M
Shares Float: 81.93M
% Insiders: 41.70%
% Institutions: 4,730.30%
Short % Float: 22.57%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Small Cap Growth 5.65M 6.86% ▼ 5.57% Mar 31, 2026
2 Fidelity Small Cap Growth K6 2.83M 3.43% ▼ 5.28% Mar 31, 2026
3 Vanguard Total Stock Mkt Idx Inv 2.15M 2.61% ▲ 3.19% Apr 30, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 738.66K 0.90% ▲ 0.00% Apr 30, 2026
5 Fidelity Extended Market Index 389.47K 0.47% ▼ 0.36% Apr 30, 2026
6 Extended Equity Market Fund B 200.19K 0.24% ▲ 59.19% Dec 31, 2025
7 Blackrock Extended Mkt Fund CF 200.19K 0.24% ▲ 0.00% Apr 30, 2026
8 Extended Equity Market Fund E 200.19K 0.24% ▲ 59.19% Dec 31, 2025
9 Bridgeway Ultra-Small Company 173.00K 0.21% ▲ 0.00% Mar 31, 2026
10 BlackRock Extended Equity Market Fund K 170.46K 0.21% ▼ 0.73% Mar 31, 2026

Valuation Metrics

Enterprise Value: $61.93M
Trailing P/E: 0.00
Forward P/E: 16.58

Financial Highlights

Market Cap: $90.50M
EBITDA: $-82.36M
PEG Ratio: $0.00
Book Value: $0.07
Earnings/Share: $-1.58
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -76.36%
ROE (TTM): -296.36%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 1.40x 0.12x 0.68x N/A -0.03x
2024-12-31 2.77x 0.04x 0.39x -632.05x -0.02x
2023-12-31 3.60x 0.16x 0.31x -117.71x -0.15x
2022-12-31 3.25x 0.09x 0.36x -213.38x -0.07x
2021-12-31 6.82x 0.04x 0.19x -155.55x -0.06x
2020-12-31 11.30x 0.05x 0.15x -14.26x -0.14x
2019-12-31 2.94x 23.03x 0.96x -13.98x -0.74x
2018-12-31 2.49x 0.00x 0.34x -271.87x 0.00x
2017-12-31 3.91x 0.18x 0.24x -3,225.35x -0.30x
2016-12-31 2.84x 0.17x 0.29x -547.48x -0.28x
2015-12-31 5.46x 0.07x 0.18x -6.62x -0.35x
2014-12-31 7.02x 0.06x 0.15x -11.77x -0.17x
2013-12-31 2.03x 0.10x 0.40x -0.22x -0.26x
2012-12-31 1.91x 0.11x 0.23x -4.76x -0.16x
2011-12-31 2.89x 0.09x 0.22x -631.14x -0.20x
2010-12-31 3.55x 0.00x 0.16x -12.75x 0.00x
2009-12-31 2.30x 0.20x 0.24x -1.33x -0.87x
2008-12-31 1.04x 0.63x 0.51x -278.71x -1.01x
2007-12-31 8.65x 0.00x 0.22x -4.65x 0.00x
2006-12-31 3.57x 0.00x 0.35x N/A 0.00x
2005-12-31 4.43x 0.00x 0.19x -4.66x 0.00x
2004-12-31 3.41x 0.20x 0.26x N/A -0.28x
2003-12-31 11.87x 0.02x 0.07x -323.89x -0.05x
2002-12-31 1.63x 0.01x 0.31x -1,089.98x 0.00x
2001-12-31 2.25x 0.01x 0.25x -273.61x -0.01x
2000-12-31 5.45x 0.01x 0.14x -391.69x -0.01x
1999-12-31 5.52x 0.01x 0.16x -283.46x -0.01x
1998-12-31 5.43x 0.00x 0.15x -283.46x 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about INO.US!